Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

Building a big nest egg for your post-work life by buying stocks is very possible, but it requires patience, investing in the ...

This stock could make you a fortune in the next two years, or lose you a whole lot of money.

Longeveron shares rip higher as the biotech firm raises $30 million via a private placement. Here’s why it may not be too ...

Ligand Pharmaceuticals is Tuesday's IBD Stock Of The Day. The biotech stock has blown past several buy points on its way to a new breakout.

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more ...

Intellia is a mid-cap biotech company specializing in gene editing and developing medicines for diseases for which few exist.

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering rate, especially among the Mag Seven AI darlings, all while the question ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

At today's Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all agenda items with a broad majority. Dr.